Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
12/2009
12/30/2009CN101613689A Cellulose enzyme activity promoter and preparation method thereof
12/30/2009CN101613688A Von willebrand factor (vWF)-cleaving protease
12/30/2009CN101613687A Recombinant bovine enterokinase, preparation method and use thereof
12/30/2009CN101613686A Beer compound enzyme
12/30/2009CN101613685A Combined chitinase for deactivating varroa destructor and application thereof
12/30/2009CN101613684A Chitinase for deactivating varroa destructor, serratia marcescens and application thereof
12/30/2009CN101613683A Chitinase ChiB for deactivating varroa destructor and application thereof
12/30/2009CN101613682A Chitinase ChiCl for deactivating varroa destructor and application thereof
12/30/2009CN101613681A Method for renaturing and purifying recombinant extremely heat-resistant alpha-amylase
12/30/2009CN101613680A Moloney murine leukemia virus reverse transcriptase mutant as well as expression method and application thereof
12/30/2009CN100575492C CDNA sequence of coding perinereis albuhitensis grube protease and amino acid sequence thereof
12/30/2009CN100575487C Method for producing 5'-flavour development nucleic acid
12/30/2009CN100575485C Targeted chromosomal mutagenesis using zinc finger nucleases
12/30/2009CN100575484C Beta-glucosidase and its coding gene and application
12/30/2009CN100575483C Method of preparing heat-proof xylanase, heat-proof beta-xylosidase or heat-proof beta-glucosidase
12/30/2009CN100575478C Novel vibrionaceae vibrio bacterial strain and application thereof
12/30/2009CA2729375A1 Improved protein production and storage in plants
12/30/2009CA2728933A1 Bridged secondary amines and use thereof as iap bir domain binding compounds
12/30/2009CA2728789A1 Nitric oxide compositions and devices and methods for cosmesis
12/30/2009CA2726894A1 Therapeutic agents comprising elastin-like peptides
12/29/2009US7638620 Use to enhance apoptosis; antiproliferative agents
12/29/2009US7638616 Use in detergents; use in conversion of cellulose to glucose; mutant enzyme has improved properties over parent enzyme such as thermostability, pH activity, pH stability, substrate specificity, and chemical stability; vectors, host cells
12/29/2009US7638613 For use in the treatment of paper pulp, stable over wide temperature and pH range
12/29/2009US7638598 ErbB interface peptidomimetics and methods of use thereof
12/29/2009US7638497 For enhancing apoptosis and treating proliferative disorders; antitumor agents
12/29/2009US7638331 chimeric gene construct composed of a COX-2 promoter operably linked to at least one apoptosis-inducing gene that can cause selectively induced apoptosis in a population of diseased cells; entire classes of cells can be treated with one transfection
12/29/2009US7638323 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering
12/29/2009US7638317 improved polypeptides by substituting or deleting specified amino acids in fungal lipolytic enzymes; reduction of dough stickiness when they are added to a dough
12/29/2009US7638316 Culturing cell comprising exogenous nucleic acid molecule encoding polypeptide capable of producing 3-hydroxypropionic acid from phosphoenolpyruvate (PEP), pyruvate, or lactate
12/29/2009US7638315 Nucleic acid with beta-keto acyl-ACP synthase (KS) activity, chain length factor (CLF) activity, acyl transferase (AT) activity, and enoyl ACP-reductase (ER) activity; biosynthesis of polyunsaturated fatty acids (PUFAs)
12/29/2009US7638312 E.coli mutant containing mutant genes related with tryptophan biosynthesis and production method of tryptophan by using the same
12/29/2009US7638311 using branching enzyme from a bacterium of the genus Neisseria; for use in pharmaceutical/cosmetic industries
12/29/2009US7638306 Process of increasing cellular production of biologically active compounds
12/29/2009US7638300 In vivo incorporation of unnatural amino acids
12/29/2009US7638297 Compositions for protein biosynthetic machinery; orthogonal lysyl-tRNAs, orthogonal lysyl-aminoacyl-tRNA synthetases and orthogonal pairs of lysyl-tRNAs/synthetases which incorporate homoglutamines into proteins are provided in response to four base codon; biosynthesis enzyme; therapeutic use
12/29/2009US7638295 Identifying agent which modulates 2-oxoglutarate dependent oxygenase; ankyrin substrate; hypoxia-inducible factor; thalassemia
12/29/2009US7638293 Method
12/29/2009US7638277 Diagnosing ovarian cancer by detecting a TADG-12 protein in biological sample, immunoaffinity to an antibody, bioassay, immunoassay
12/29/2009US7638276 Using encapuslated gene sequences as tools for directed evolution of nucleic acids; microencapsulation and gene expression
12/29/2009US7638149 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
12/29/2009US7638131 Coccidiosis poultry vaccine
12/29/2009CA2331783C Chemically modified proteins with a carbohydrate moiety
12/29/2009CA2302385C Gene encoding .alpha.-subunit of rice anthranilate synthase and dna relating thereto
12/29/2009CA2263726C Transgenic plants expressing cellulolytic enzymes
12/29/2009CA2201885C Dna polymerases having modified nucleotide binding site for dna sequencing
12/24/2009US20090320158 Protein Kinase Stress-Related Proteins and Methods of Use in Plants
12/24/2009US20090320157 Transgenic freeze and drought resistant plants; crops with enhanced resistance to enviromental stresses; plant transformed by a Protein Kinase Stress-Related Protein (PKSRP) coding nucleic acid
12/24/2009US20090318672 Antibodies to pro352
12/24/2009US20090318487 Methods for detection of promoter polymorphism in a UGT gene promoter
12/24/2009US20090318441 Pyrrolopyrimidine Compounds and Their Uses
12/24/2009US20090318372 Method For Producing 2-O-Glyceryl-Alpha-D-Glucopyranoside
12/24/2009US20090318368 Angiotensin-converting enzyme inhibitory peptides
12/24/2009US20090318349 Transglutaminase variants with improved specificity
12/24/2009US20090318340 IL-17 homologous polypeptides and therapeutic uses thereof
12/24/2009US20090317891 Plant activation of insect toxin
12/24/2009US20090317890 Fibrionolytic metalloprotease and composition comprising the same
12/24/2009US20090317889 Purification of Proteins With Cationic Surfactant
12/24/2009US20090317888 Thermus egertssonii dna polymerases
12/24/2009US20090317871 Bacillus licheniformis b1, alkalophilic enzyme solution and method of producing the same
12/24/2009US20090317868 Rapidly Cleavable Sumo Fusion Protein Expression System for Difficult to Express Proteins
12/24/2009US20090317865 Eubacterial RNA-Polymerase Mutants With Altered Product Production
12/24/2009US20090317864 Alpha-Amylase Mutants
12/24/2009US20090317851 Hemoglobin a1c determination method, enzyme to be used therefor, and production method thereof
12/24/2009US20090317850 Crystal Structure of Human 70KD Ribosomal Protein S6 Kinase 1 Kinase Domain
12/24/2009US20090317825 Assay for parkinson's disease therapeutics and enzymatically active parkin preparations useful therein
12/24/2009US20090317515 Solid enzyme formulations and process for their preparation
12/24/2009US20090317396 Antibody specifically binding to dr5 and composition for preventing or treating cancers comprising the same
12/24/2009US20090317373 Inhibition of the Anti-FVIII Immune Response
12/24/2009US20090317358 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
12/24/2009US20090314286 Geobacillus Stearothermophilus Alpha-Amylase (AmyS) Variants with Improved Properties
12/24/2009DE102008029401A1 Verfahren zur Kristallisation von Peptiden und Proteinen A method for crystallization of proteins and peptides
12/23/2009WO2009155609A1 IMMUNOGENIC MEMAPSIN 2 β-SECRETASE PEPTIDES AND METHODS OF USE
12/23/2009WO2009155464A2 Mutated and chemically modified thermally stable dna polymerases
12/23/2009WO2009155115A2 Coatings and surface treatments having active enzymes and peptides
12/23/2009WO2009155108A1 Saccharide structures and methods of making and using such structures
12/23/2009WO2009154686A1 Compositions for linking dna-binding domains and cleavage domains
12/23/2009WO2009154502A1 Method for producing a combined preparation exhibiting collagenase activity
12/23/2009WO2009154247A1 Thermostable 1,5-anhydroglucitol dehydrogenase, and method for measurement of 1,5-anhydroglucitol by using the same
12/23/2009WO2009153208A1 Plants having enhanced yield-related traits and a method for making the same
12/23/2009WO2009153047A2 Biotechnological production of acrylic acid
12/23/2009WO2009133379A3 Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof
12/23/2009WO2009129489A9 Buttiauxella sp. phytase variants
12/23/2009WO2008130603A3 Increased ethanol production from xylose
12/23/2009EP2135946A1 Method for production of polypeptide
12/23/2009EP2135944A1 Endoglucanase ppce and cellulase preparation containing the same
12/23/2009EP2135943A1 Assay electrode having immobilized lipid/protein layers, methods of making the same and methods of using the same for luminescence test measurements
12/23/2009EP2135504A1 Non-transgenic herbicide resistant plants
12/23/2009EP2134850A1 Generation of chemical building blocks from plant biomass by selective depolymerization
12/23/2009EP2134839A1 Herbicide-resistant sunflower plants with multiple herbicide resistant alleles of ahasl1 and methods of use
12/23/2009EP2134838A2 Concentrate of protein c containing protein s, its preparation and use
12/23/2009EP2134837A1 Delta 9 elongases and their use in making polyunsaturated fatty acids
12/23/2009EP2134365A1 Compositions and methods for inhibiting tumor cell growth
12/23/2009EP2134355A2 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions
12/23/2009EP2134159A2 Ahas mutants
12/23/2009EP1743040B1 Hdm2-inhibitor complexes and uses thereof
12/23/2009EP1383874B1 Variants of lipoxygenase and their use
12/23/2009EP1341808B1 Synthetic nucleic acid molecule compositions and methods of preparation
12/23/2009EP1312259B1 Type iii allergic inflammation model animal
12/23/2009EP0942989B1 Method for the production of 1,3-propanediol by recombinant organisms
12/23/2009CN101611141A R-HNL random variants and their use for preparing optically pure, sterically hindered cyanohydrins